CALLISTO PHARMACEUTICALS INC Retained Earnings
CALLISTO PHARMACEUTICALS INC had Retained Earnings of -$59.11 million as of 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2012-11-19
- 2012-09-30: Retained Earnings (Accumulated Deficit) -$59.11M.
- 2012-06-30: Retained Earnings (Accumulated Deficit) -$55.21M.
- 2012-03-31: Retained Earnings (Accumulated Deficit) -$145.51M.
- 2011-12-31: Retained Earnings (Accumulated Deficit) -$142.37M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2012-09-30 | -$59.11M 10-Q · filed 2012-11-19 |
| 2012-06-30 | -$55.21M 10-Q/A · filed 2012-08-28 |
| 2012-03-31 | -$145.51M 10-Q · filed 2012-05-15 |
| 2011-12-31 | -$142.37M 10-Q · filed 2012-11-19 |
| 2011-09-30 | -$140.35M 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$139.84M 10-Q · filed 2011-08-15 |
| 2010-12-31 | -$135.57M 10-K · filed 2012-03-30 |